Javascript must be enabled to continue!
Interrelationships Between Angiotensin, Norepinephrine, Epinephrine, Aldosterone Secretion, and Electrolyte Metabolism in Man
View through CrossRef
Oversecretion of aldosterone is a consistent finding in the syndrome of malignant hypertension. Infusion of angiotensin has been consistently shown to induce an increased secretion of aldosterone by the adrenal cortex in normal human subjects. Because renal damage is so prominent in malignant hypertension, it seems possible that renin release and then aldosterone oversecretion by the adrenal cortex are involved in the pathogenesis of this disorder.
These findings support the possibility that there is a renal-adrenal system which operates for the normal regulation of electrolyte balance. This system might function to maintain and protect renal perfusion by promoting sodium retention via stimulation of the adrenal cortex.
Our recent work has been predicated on the possibility that aldosterone secretion is chiefly regulated by 1 specific trophic hormone (possibly angiotensin), oversecretion of which accounts for the increased secretion of aldosterone observed in various other conditions.
Preliminary studies designed to investigate the possible role of angiotensin in the marked oversecretion of aldosterone found in cirrhosis have been reported. It has been observed that patients with cirrhosis and ascites may be less sensitive to both angiotensin and norepinephrine so that more drug is required to produce a given pressor response. Further-more, aldosterone secretion could not be augmented by administering angiotensin in these patients. While several interpretations are possible, these findings are consistent with the view that the adrenal cortex is already maximally stimulated by circulating endogenous angiotensin.
Because of reduced pressor responsiveness, increased amounts of angiotensin could circulate without causing hypertension. This hypothesis awaits actual demonstration of increased amounts of circulating renin or angiotensin in this condition (and others) associated with aldosteronism.
Proper study of the interrelationships between pressor substances, aldosterone secretion, and sodium balance requires that effects of the different types of pressor agents be compared under similar circumstances. Thus, both norepinephrine and angiotensin affect the renal excretion of electrolytes. Both can cause a natriuresis in normal or hypertensive subjects. In normal subjects, the natriuresis occurs inconsistently but seems more readily induced after sodium depletion.
Angiotensin has been found to produce a marked increase in sodium excretion in patients with cirrhosis and ascites who have increased aldosterone secretion. In equipressor doses, the natriuresis of angiotensin is of strikingly greater magnitude than that of norepinephrine, possibly indicating that the peptide affects tubular transport of sodium. The natriuresis effected by these pressor agents seems independent of their effect on aldosterone secretion because medullary hormones often suppress aldosterone output, whereas angiotensin increases it.
Further study is necessary to define more specifically the conditions which determine these responses and interrelationships. The results to date support the view that an aldosterone-regulating hormone (possibly angiotensin) could be elaborated as a result of a critical change in intrarenal pressure.
Title: Interrelationships Between Angiotensin, Norepinephrine, Epinephrine, Aldosterone Secretion, and Electrolyte Metabolism in Man
Description:
Oversecretion of aldosterone is a consistent finding in the syndrome of malignant hypertension.
Infusion of angiotensin has been consistently shown to induce an increased secretion of aldosterone by the adrenal cortex in normal human subjects.
Because renal damage is so prominent in malignant hypertension, it seems possible that renin release and then aldosterone oversecretion by the adrenal cortex are involved in the pathogenesis of this disorder.
These findings support the possibility that there is a renal-adrenal system which operates for the normal regulation of electrolyte balance.
This system might function to maintain and protect renal perfusion by promoting sodium retention via stimulation of the adrenal cortex.
Our recent work has been predicated on the possibility that aldosterone secretion is chiefly regulated by 1 specific trophic hormone (possibly angiotensin), oversecretion of which accounts for the increased secretion of aldosterone observed in various other conditions.
Preliminary studies designed to investigate the possible role of angiotensin in the marked oversecretion of aldosterone found in cirrhosis have been reported.
It has been observed that patients with cirrhosis and ascites may be less sensitive to both angiotensin and norepinephrine so that more drug is required to produce a given pressor response.
Further-more, aldosterone secretion could not be augmented by administering angiotensin in these patients.
While several interpretations are possible, these findings are consistent with the view that the adrenal cortex is already maximally stimulated by circulating endogenous angiotensin.
Because of reduced pressor responsiveness, increased amounts of angiotensin could circulate without causing hypertension.
This hypothesis awaits actual demonstration of increased amounts of circulating renin or angiotensin in this condition (and others) associated with aldosteronism.
Proper study of the interrelationships between pressor substances, aldosterone secretion, and sodium balance requires that effects of the different types of pressor agents be compared under similar circumstances.
Thus, both norepinephrine and angiotensin affect the renal excretion of electrolytes.
Both can cause a natriuresis in normal or hypertensive subjects.
In normal subjects, the natriuresis occurs inconsistently but seems more readily induced after sodium depletion.
Angiotensin has been found to produce a marked increase in sodium excretion in patients with cirrhosis and ascites who have increased aldosterone secretion.
In equipressor doses, the natriuresis of angiotensin is of strikingly greater magnitude than that of norepinephrine, possibly indicating that the peptide affects tubular transport of sodium.
The natriuresis effected by these pressor agents seems independent of their effect on aldosterone secretion because medullary hormones often suppress aldosterone output, whereas angiotensin increases it.
Further study is necessary to define more specifically the conditions which determine these responses and interrelationships.
The results to date support the view that an aldosterone-regulating hormone (possibly angiotensin) could be elaborated as a result of a critical change in intrarenal pressure.
Related Results
ALDOSTERONE IS A VASCULAR CALCIFICATION PROMOTING FACTOR
ALDOSTERONE IS A VASCULAR CALCIFICATION PROMOTING FACTOR
Objectives
Aim: To observe aortic and cardiac aldosterone expression and its receptor changes in rats with vascular calcification, and exogenous aldosterone effec...
CHANGES IN PLASMA ALDOSTERONE FOLLOWING THE ADMINISTRATION OF VARIOUS COMBINATIONS OF STIMULI
CHANGES IN PLASMA ALDOSTERONE FOLLOWING THE ADMINISTRATION OF VARIOUS COMBINATIONS OF STIMULI
ABSTRACT
The effects on plasma aldosterone levels of combinations of the main factors involved in aldosterone regulation have been studied in normal young male subjects. Th...
GW24-e2104 Epinephrine enhanced LPS-induced pro-inflammatory cytokines release by BMMCs: a cross-talking between catecholamine, circadian rhythm and inflammation
GW24-e2104 Epinephrine enhanced LPS-induced pro-inflammatory cytokines release by BMMCs: a cross-talking between catecholamine, circadian rhythm and inflammation
Objectives
Occurring of acute coronary syndromes (ACSs) displayed circadian rhythms as well as the levels of catecholamines and pro-inflammatory cytokines in vivo...
THE ROLE OF EPINEPHRINE IN THE REACTIONS PRODUCED BY THE ENDOTOXINS OF GRAM-NEGATIVE BACTERIA
THE ROLE OF EPINEPHRINE IN THE REACTIONS PRODUCED BY THE ENDOTOXINS OF GRAM-NEGATIVE BACTERIA
The effects of endotoxin on the epinephrine reactivity of blood vessels in the rat mesoappendix have been studied. Following intravenous injection of a relatively small, sublethal ...
Abstract 125: Modified Angiotensin II Has Lower Vasoconstrictive Effect Than Angiotensin II
Abstract 125: Modified Angiotensin II Has Lower Vasoconstrictive Effect Than Angiotensin II
Introduction:
The renin-angiotensin-aldosterone system (RAAS) is involved in the regulation of the blood pressure, water- and electrolyte balance. Pathophysiologically,...
CDP-CHOLINE IMPROVES THE OUTCOME OF CARDIAC ARREST VERSUS EPINEPHRINE IN RATS
CDP-CHOLINE IMPROVES THE OUTCOME OF CARDIAC ARREST VERSUS EPINEPHRINE IN RATS
Objectives
CDP-Choline is a cholinergic agent which can both stimulate the cholinergic pathway and increase blood pressure. We aimed to investigate the effects of...
Outcomes with intracoronary vs. intravenous epinephrine in cardiac arrest
Outcomes with intracoronary vs. intravenous epinephrine in cardiac arrest
Abstract
Background
Advanced Cardiovascular Life Support (ACLS) guidelines recommend intravenous (IV) and intraosseous (IO) epin...
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Angiotensin II has been shown to be a potent agent in the acceleration of wound repair. Angiotensin (1‐7), a fragment of angiotensin II that is not hypertensive, was found to be co...

